Whole Shine Medical Technology Co., Ltd. (002622.SZ)
- Previous Close
2.4300 - Open
2.5400 - Bid 2.5000 x --
- Ask 2.5100 x --
- Day's Range
2.4500 - 2.5100 - 52 Week Range
1.1500 - 4.1000 - Volume
17,720,187 - Avg. Volume
29,925,747 - Market Cap (intraday)
2.1B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 23, 2015
- 1y Target Est
--
Whole Shine Medical Technology Co., Ltd. engages in the traditional manufacturing, oral medical, and other businesses in China. The company is involved in the research and development, production, and sale of high and low voltage permanent magnet circuit breakers, contactors, and high and low voltage complete sets of equipment, as well as permanent magnet switches, switchgears, intelligent control devices, switch state controllers, and outdoor box-type substations. It also engages in the diagnosis and treatment of oral diseases, as well as provision of oral health care, restoration, and other oral medical services. In addition, the company provides banking services to small and micro enterprises, urban and rural residents, and the local economy. The company was formerly known as Rongyu Group Co.,Ltd. and changed its name to Whole Shine Medical Technology Co., Ltd. in December 2022. Whole Shine Medical Technology Co., Ltd. was founded in 1986 and is based in Beijing, China.
www.wholeshinemedical.com1,818
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: 002622.SZ
View MorePerformance Overview: 002622.SZ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002622.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002622.SZ
View MoreValuation Measures
Market Cap
2.10B
Enterprise Value
2.44B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.49
Price/Book (mrq)
5.50
Enterprise Value/Revenue
2.90
Enterprise Value/EBITDA
101.85
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.20%
Return on Assets (ttm)
2.97%
Return on Equity (ttm)
-11.79%
Revenue (ttm)
868.1M
Net Income Avi to Common (ttm)
-97.19M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
154.84M
Total Debt/Equity (mrq)
101.20%
Levered Free Cash Flow (ttm)
64.7M